Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel B Shin

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
The Journal of Investigative Dermatology|July 22, 2019
A Phase IV, Randomized, Double-Blind, Placebo-Controlled Crossover Study of the Effects of Ustekinumab on Vascular Inflammation in Psoriasis (the VIP-U Trial)Joel M Gelfand, Daniel B Shin, Abass Alavi, et al.
Journal of the American Academy of Dermatology|June 5, 2014
Palmoplantar psoriasis is associated with greater impairment of health-related quality of life compared with moderate to severe plaque psoriasisJina Chung, Kristina Callis Duffin, Junko Takeshita, et al.
The Journal of Investigative Dermatology|May 24, 2013
IL-31 is produced by the malignant T-cell population in cutaneous T-Cell lymphoma and correlates with CTCL pruritusElisha M Singer, Daniel B Shin, Leigh A Nattkemper, et al.
Journal of the American Academy of Dermatology|January 18, 2019
Prevalence of clinically significant incidental findings by whole-body fludeoxyglucose F 18 positron emission tomography/computed tomography scanning in moderate-to-severe psoriasis patients participating in clinical trialsMarilyn T Wan, Drew A Torigian, Abass Alavi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
Hypoxia and Photofrin uptake in the intraperitoneal carcinomatosis and sarcomatosis of photodynamic therapy patientsTheresa M Busch, Stephen M Hahn, E Paul Wileyto, et al.
The British Journal of Dermatology|April 28, 2026
Genetic proxies of GLP1R expression are associated with lower risk of psoriasis and psoriatic arthritisRavi Ramessur, Alya G A Arham, Jake Saklatvala, et al.
Archives of Dermatology|August 17, 2011
High clinical response rate of Sezary syndrome to immunomodulatory therapies: prognostic markers of responseBrian A Raphael, Daniel B Shin, Karen R Suchin, et al.
The Journal of Investigative Dermatology|April 23, 2021
Impact of Biological Agents on Imaging and Biomarkers of Cardiovascular Disease in Patients with Psoriasis: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled TrialsAlvaro González-Cantero, Daniel Ortega-Quijano, Noelia Álvarez-Díaz, et al.
JAMA Dermatology|August 13, 2015
Reliability and Validity of Cutaneous Sarcoidosis Outcome Instruments Among Dermatologists, Pulmonologists, and RheumatologistsHowa Yeung, Sara Farber, Belinda K Birnbaum, et al.
JAMA Dermatology|January 21, 2026
Discordance in Treatment Response Assessment Between Clinicians and Patients With Skin Chronic Graft-vs-Host DiseaseVarshini Babu, Daniel B Shin, Lynn Onstad, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
The Journal of Investigative Dermatology|July 22, 2019
A Phase IV, Randomized, Double-Blind, Placebo-Controlled Crossover Study of the Effects of Ustekinumab on Vascular Inflammation in Psoriasis (the VIP-U Trial)Joel M Gelfand, Daniel B Shin, Abass Alavi, et al.
Journal of the American Academy of Dermatology|June 5, 2014
Palmoplantar psoriasis is associated with greater impairment of health-related quality of life compared with moderate to severe plaque psoriasisJina Chung, Kristina Callis Duffin, Junko Takeshita, et al.
The Journal of Investigative Dermatology|May 24, 2013
IL-31 is produced by the malignant T-cell population in cutaneous T-Cell lymphoma and correlates with CTCL pruritusElisha M Singer, Daniel B Shin, Leigh A Nattkemper, et al.
Journal of the American Academy of Dermatology|January 18, 2019
Prevalence of clinically significant incidental findings by whole-body fludeoxyglucose F 18 positron emission tomography/computed tomography scanning in moderate-to-severe psoriasis patients participating in clinical trialsMarilyn T Wan, Drew A Torigian, Abass Alavi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
Hypoxia and Photofrin uptake in the intraperitoneal carcinomatosis and sarcomatosis of photodynamic therapy patientsTheresa M Busch, Stephen M Hahn, E Paul Wileyto, et al.
The British Journal of Dermatology|April 28, 2026
Genetic proxies of GLP1R expression are associated with lower risk of psoriasis and psoriatic arthritisRavi Ramessur, Alya G A Arham, Jake Saklatvala, et al.
Archives of Dermatology|August 17, 2011
High clinical response rate of Sezary syndrome to immunomodulatory therapies: prognostic markers of responseBrian A Raphael, Daniel B Shin, Karen R Suchin, et al.
The Journal of Investigative Dermatology|April 23, 2021
Impact of Biological Agents on Imaging and Biomarkers of Cardiovascular Disease in Patients with Psoriasis: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled TrialsAlvaro González-Cantero, Daniel Ortega-Quijano, Noelia Álvarez-Díaz, et al.
JAMA Dermatology|August 13, 2015
Reliability and Validity of Cutaneous Sarcoidosis Outcome Instruments Among Dermatologists, Pulmonologists, and RheumatologistsHowa Yeung, Sara Farber, Belinda K Birnbaum, et al.
JAMA Dermatology|January 21, 2026
Discordance in Treatment Response Assessment Between Clinicians and Patients With Skin Chronic Graft-vs-Host DiseaseVarshini Babu, Daniel B Shin, Lynn Onstad, et al.
Pageof 10